Drug Shortage Report for NXSTAGE PUREFLOW SOLUTION RFP-209-CAN

Last updated on 2019-03-12 History
Report ID 76025
Drug Identification Number 02443295
Brand name NXSTAGE PUREFLOW SOLUTION RFP-209-CAN
Common or Proper name Hemodialysis Solution
Company Name NXSTAGE MEDICAL INC
Active Ingredient(s) SODIUM LACTATE DEXTROSE MAGNESIUM CHLORIDE CALCIUM CHLORIDE POTASSIUM CHLORIDE SODIUM CHLORIDE
Strength(s) 8.408G 1.1G 0.102G 0.221G 0.15G 5.552G
Dosage form(s) SOLUTION
Route of administration DIALYSIS
Packaging size 5 L
ATC code B05Z
ATC description HEMODIALYTICS AND HEMOFILTRATES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-02-11
Estimated end date Unknown
Actual end date 2019-03-11
Shortage status Resolved
Updated date 2019-03-12
Company comments
Health Canada comments
Contact Address 350 MERRIMACK STREET
LAWRENCE, MASSACHUSETTS
UNITED STATES 01843
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-02-15 English Compare
v2 2019-02-15 English Compare
v3 2019-02-15 French Compare
v4 2019-02-15 English Compare
v5 2019-02-15 French Compare
v6 2019-03-11 English Compare
v7 2019-03-11 English Compare
v8 2019-03-11 English Compare
v9 2019-03-11 French Compare
v10 2019-03-12 English Compare